Villanueva, Necasio B.

HRN: 03-07-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2025
CEFTRIAXONE 1G (VIAL)
05/14/2025
05/20/2025
IV
2g
OD
Cap-mr; T/c PTB RELAPSE
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes